Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
Saved in:
| Title: | Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer. |
|---|---|
| Authors: | de Heer, E. C.1 (AUTHOR), Zois, C. E.2,3,4 (AUTHOR) christos.zois@oncology.ox.ac.uk, Bridges, E.2 (AUTHOR), van der Vegt, B.5 (AUTHOR), Sheldon, H.2 (AUTHOR), Veldman, W. A.1 (AUTHOR), Zwager, M. C.5 (AUTHOR), van der Sluis, T.5 (AUTHOR), Haider, S.6 (AUTHOR), Morita, T.7 (AUTHOR), Baba, O.7 (AUTHOR), Schröder, C. P.1,8 (AUTHOR), de Jong, S.1 (AUTHOR), Harris, A. L.2 (AUTHOR), Jalving, M.1 (AUTHOR) m.jalving@umcg.nl |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 8/28/2023, Vol. 42 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
